Alpha Cognition EBITDA Margin 2020-2024 | ACOG
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Alpha Cognition (ACOG) over the last 10 years. The current EBITDA margin for Alpha Cognition as of June 30, 2024 is .
| Alpha Cognition EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
